|
2ND UPDATE: C.R. Bard to Pay $48.3 Million to Settle Kickback Case -DOJ
|
7:22 PM |
May 13, 2013 |
Dow Jones Global News Select
|
|
LONDON MARKETS: GSK, Shell Lead U.K. Stocks To 8th Day Of Gains
|
12:07 PM |
May 13, 2013 |
Dow Jones Global News Select
|
|
LONDON MARKETS: GSK, Shell Lead U.K. Stocks To 8th Day Of Gains
|
12:07 PM |
May 13, 2013 |
Dow Jones Global News Select
|
|
EUROPE MARKETS: Europe Stocks Retreat From 2013 High
|
12:04 PM |
May 13, 2013 |
Dow Jones Global News Select
|
|
Elan Signs $1 Billion Drug Deal
|
5:44 AM |
May 13, 2013 |
Dow Jones Global News Select
|
|
Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact
|
2:34 AM |
May 13, 2013 |
Dow Jones Global News Select
|
|
Where European Investors Look for Value
|
2:55 PM |
May 13, 2013 |
Barrons.com
|
|
(PR) BREO(TM) ELLIPTA(TM) gains US approval for -2-
|
3:59 PM |
May 10, 2013 |
PR
|
|
(PR) BREO(TM) ELLIPTA(TM) gains US approval for the treatment of COPD
|
3:59 PM |
May 10, 2013 |
PR
|
|
UPDATE: FDA Approves GlaxoSmithKline's Breo Ellipta to Treat Lung Disease
|
2:32 PM |
May 10, 2013 |
Dow Jones Global News Select
|
|
BREO(TM) ELLIPTA(TM) Gains US Approval for the -2-
|
12:37 PM |
May 10, 2013 |
PR
|
|
BREO(TM) ELLIPTA(TM) Gains US Approval for the Treatment of COPD
|
12:37 PM |
May 10, 2013 |
PR
|
|
GSK, Theravance See Breo Ellipta Available in 3Q13 After FDA Approval
|
12:27 PM |
May 10, 2013 |
Dow Jones Global News Select
|
|
FDA OKs GlaxoSmithKline Drug to Treat Lung Disease
|
12:15 PM |
May 10, 2013 |
Dow Jones Global News Select
|
|
FDA Approves GlaxoSmithKline's Breo Ellipta to Treat Lung Disease
|
12:00 PM |
May 10, 2013 |
Dow Jones Global News Select
|
|
The Morning Download: Pharma Trialed Big Brother Tech
|
7:59 AM |
May 2, 2013 |
WSJ.com
|
|
Glaxo Mined Online Parent Discussion Boards For Vaccine Worries
|
8:53 PM |
May 1, 2013 |
WSJ.com
|
|
Companies Serving Consumers in India Are M&A Targets
|
2:21 PM |
May 1, 2013 |
Dow Jones Global News Select
|
|
Companies Serving Consumers in India Are M&A Targets
|
2:06 PM |
May 1, 2013 |
Dow Jones Global News Select
|
|
GlaxoSmithKline Gets 3 Month Extension to Trametinib PDUFA Goal Date
|
7:55 AM |
May 1, 2013 |
Dow Jones Global News Select
|
